Merck outflanks Pfizer's 20-valent shot with pneumococcal vaccine approval for kids
Back in April, the FDA asked for more analysis from Merck on its 15-valent pneumococcal vaccine for children and pushed back its approval deadline by …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
